Other Diseases or Conditions | PatientNCT01414829
Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment
An observational study of Other Diseases or Conditions | Patient, run by The Baruch Padeh Medical Center, Poriya.
Trial summary
Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture. Read more about this study
- Who is it for?
- Ages 10 years and older
- Conditions the study is for
- Other Diseases or Conditions | Patient
- What is being tested?
- Gastroscopy
- Type of treatment
- Surgery or procedure
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Aug 2011to Jan 2012
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patient referred for gastroscopy because of clinical reasons
Who may be able to join
- all referred for gastroscopy with clinical or endoscopic signs of peptic disease
Who cannot join
- coagulation disorders
- pregnant women
About this study
Official title: Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure
Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.
- Conditions
- Other Diseases or Conditions | Patient
- Being tested
- Gastroscopy
- Keywords
- Peptic disease, Helicobacter pylori, Different methods
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GastroscopyProcedure or surgery
The reason for gastroscopy will be not related to the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Aug 2011 (estimated)
- Study startAug 2011
- Primary completionJan 2012 (estimated)
- Study completionJan 2012
Why it stopped: difficulty in recruiting parients
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Other Diseases or Conditions | PatientStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- The Baruch Padeh Medical Center, Poriya
- Sponsor type
- Other government
- Investigators
- Maya PAritsky, MD, Principal investigator, Baruch Padeh MC, Israel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01414829
- Sponsor's protocol ID
- paritsky1.ct.il
- Status last verified
- Dec 2012
- First submitted
- 10 Aug 2011
- Last updated
- 4 Dec 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Dec 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure
- ClinicalTrials.gov ID
- NCT01414829
- Acronym / sponsor ID
- paritsky1.ct.il
- Conditions
- Other Diseases or Conditions | Patient
- Keywords
- Peptic disease, Helicobacter pylori, Different methods
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: difficulty in recruiting parients
- Enrolment
- 0 participants (actual)
- Lead sponsor
- The Baruch Padeh Medical Center, PoriyaOther government
- Study start
- Aug 2011
- Primary completion
- Jan 2012 (estimated)
- Study completion
- Jan 2012
- First posted
- 11 Aug 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
Who may qualify
- Ages
- 10 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patient referred for gastroscopy because of clinical reasons
Key inclusion criteria (1 listed)
- all referred for gastroscopy with clinical or endoscopic signs of peptic disease
Key exclusion criteria (2 listed)
- coagulation disorders
- pregnant women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GastroscopyThe reason for gastroscopy will be not related to the study | Procedure or surgery | – |
Primary outcome
Not reported in the source record.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Dec 2012.
Related trials for Other Diseases or Conditions | Patient
RecruitingObservational study
Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
Arterial Calcification Due to Deficiency of CD73
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingPhase 1
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Not yet recruitingPhase 1/2
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Not yet recruitingObservational study
A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies
Dermatitis, Atopic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maya PAritsky, MD principal investigator
Baruch Padeh MC, Israel
Questions about this trial
What is this clinical trial studying?
An observational study of Other Diseases or Conditions | Patient, run by The Baruch Padeh Medical Center, Poriya.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 4 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2012.